Overview

Safety Study of Abatacept to Treat Refractory Sarcoidosis

Status:
Terminated
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine how safe and effective Abatacept is in treating patients who have progressive pulmonary sarcoidosis.
Phase:
Phase 2
Details
Lead Sponsor:
University of Chicago
Collaborator:
Bristol-Myers Squibb
Treatments:
Abatacept